Page last updated: 2024-11-02

pantoprazole and Cognitive Decline

pantoprazole has been researched along with Cognitive Decline in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Pantoprazole was the most frequently used PPI agent."1.91Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany. ( Ahn, N; Baumeister, SE; Gerlach, R; Günter, A; Güntner, F; Linseisen, J; Meisinger, C; Nolde, M; Rückert-Eheberg, IM; Tauscher, M; Wawro, N, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ahn, N1
Wawro, N1
Baumeister, SE1
Nolde, M1
Gerlach, R1
Tauscher, M1
Günter, A1
Güntner, F1
Rückert-Eheberg, IM1
Meisinger, C1
Linseisen, J1

Other Studies

1 other study available for pantoprazole and Cognitive Decline

ArticleYear
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
    Drugs & aging, 2023, Volume: 40, Issue:7

    Topics: Cognitive Dysfunction; Dementia; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors

2023